United States · FDA National Drug Code directory
Dantrium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42023-124_4bcdd632-5be8-4750-a3b6-59a2b6d8f130
- Product NDC
- 42023-124
- Form
- CAPSULE
- Composition / generic term
- dantrolene sodium
- Labeler
- Par Health USA, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20080801
- Source listing expiry
- 20271231
Source-listed ingredients
- DANTROLENE SODIUM — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (42023-124-01) · 42023-124-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →